About this trial
The aim of this study is to examine the validity and reliability of the Turkish version of the Heat Sensitivity Scale in individuals with Parkinson's disease. This cross-sectional methodological study will evaluate the psychometric properties of the scale, including internal consistency, test-retest reliability, and construct validity, in order to provide a valid and reliable tool for assessing temperature sensitivity in Turkish-speaking individuals with Parkinson's disease.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Clinical diagnosis of Parkinson's disease
Hoehn and Yahr stage 1-3
Age between 40 and 85 years
Mini-Mental State Examination score ≥ 24
Disqualifiers
Presence of a major psychiatric disorder, such as major depressive disorder or a psychotic disorder
Diagnosis of advanced dementia
Presence of an uncontrolled systemic chronic disease, such as uncontrolled diabetes mellitus or hypertension
Presence of a severe cardiovascular or respiratory condition
Trial population
The study population will consist of individuals with clinically diagnosed Parkinson's disease (Hoehn and Yahr stage 1-3), aged between 40 and 85 years, with adequate cognitive function (MMSE ≥ 24). Participants will be recruited from patients attending the Movement Disorders Outpatient Clinic of the Neurology Department. The study population represents ambulatory individuals with mild to moderate disease severity suitable for comprehensive biopsychosocial assessment.
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Heat Sensitivity Scale Total Score
Heat sensitivity will be assessed using the Turkish version of the Heat Sensitivity Scale in individuals with Parkinson's disease. The scale evaluates symptoms related to heat sensitivity and their impact on daily life. The total score ranges from 29 to 116, with higher scores indicating greater heat sensitivity-related problems and therefore a worse outcome. Psychometric properties, including internal consistency, test-retest reliability, and construct validity, will be analyzed.
Secondary outcomes
Parkinson's Disease Questionnaire-39 (PDQ-39) Total and Subscale Scores
Quality of life will be assessed using the Parkinson's Disease Questionnaire-39 (PDQ-39), a validated self-report measure specific to Parkinson's disease. The questionnaire consists of 39 items across 8 domains, including mobility, activities of daily living, emotional well-being, stigma, social support, cognition, communication, and bodily discomfort. Scores can be transformed to a 0-100 scale, with higher scores indicating worse quality of life. PDQ-39 scores will be used to evaluate the construct validity of the Turkish version of the Temperature Sensitivity Scale.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.